Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell × Immunoglobulin G × Clear all

Sponsor

Conditions

Ovarian Neoplasms 14 Fallopian Tube Neoplasms 14 Glioblastoma 7 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Brenner Tumor 6 Squamous Cell Carcinoma of Head and Neck 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Melanoma 4 Gliosarcoma 4 Breast Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Recurrent Squamous Cell Lung Carcinoma 3 Oligodendroglioma 3 Urinary Bladder Neoplasms 2 Spinal Cord Neoplasms 2 Medulloblastoma 2 Glioma 2 Colonic Neoplasms 2 Carcinoma 2 Astrocytoma 2 Adenocarcinoma of Lung 2 Vipoma 1 Uveal Melanoma 1 Uterine Neoplasms 1 Urethral Neoplasms 1

Interventions

Cyclophosphamide 13 Etoposide 9 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Doxorubicin 7 Brentuximab Vedotin 7 romidepsin 6 fludarabine phosphate 6 Whole-Body Irradiation 6 Vincristine 6 Melphalan 6 fludarabine 5 Rituximab 5 Mycophenolic Acid 5 Granulocyte Colony-Stimulating Factor 4 Gemcitabine 4 Busulfan 4 10-propargyl-10-deazaaminopterin 4 pembrolizumab 3 etoposide phosphate 3 Tacrolimus 3 Lenalidomide 3 Filgrastim 3 Cytarabine 3 Carmustine 3 Antilymphocyte Serum 3 thymoglobulin 2 prednylidene 2 deltacortene 2 carmustine, poliferprosan 20 drug combination 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡